Michael Roden

83.3k citations
868 papers · 62k · 47 hit papers · h-index 109

Impact in

    • Diabetes, Cardiovascular Risks, and Lipoproteins
    • Diabetes Treatment and Management
    • Diabetes Management and Research
  • Epidemiology top 0.02%
    • Liver Disease Diagnosis and Treatment
    • Adipokines, Inflammation, and Metabolic Diseases

Papers in

    • Diabetes, Cardiovascular Risks, and Lipoproteins 143
    • Diabetes Management and Research 87
    • Diabetes Treatment and Management 71
    • Liver Disease Diagnosis and Treatment 143
    • Adipokines, Inflammation, and Metabolic Diseases 96

Michael Roden

823 papers receiving 60.3k citations

Michael Roden's Hit Papers

Metabolic Dysfunction–Associated Steatotic Liver Disease (MASLD) in People With Diabetes: The Need for Screening and Early Intervention. A Consensus Report of the American Diabetes Association 2025 · 152 citations
1520+1+2Years since publication5001k1.5k2k

Peers

Michael Roden
Comparison fields: 5 of 186
  • Endocrinology, Diabetes and Metabolism 11.6k
  • Epidemiology 16k
  • Genetics 8.3k
  • Aging 425
  • Physiology 5.7k
Replace Takashi Kadowaki with:
Takashi Kadowaki Japan
Michael Stümvoll Germany
Matthias Blüher Germany
Iichiro Shimomura Japan
Toshimasa Yamauchi Japan
Yūji Matsuzawa Japan
Jerrold M. Olefsky United States
Gökhan S. Hotamışlıgil United States
Bart Staels France
Christopher B. Newgard United States
Michael Roden relative to Takashi Kadowaki Japan Takashi Kadowaki's profile →
Citations per field
00.5×1.5×2.1×
Takashi Kadowaki · 1×
Citations per year

Countries citing papers authored by Michael Roden

Since Specialization
Citations

This map shows the geographic impact of Michael Roden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Roden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Roden more than expected).

Fields of papers citing papers by Michael Roden

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Roden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Roden. The network helps show where Michael Roden may publish in the future.

Co-authors

The 25 scholars most cited alongside Michael Roden, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michael Roden Line = papers co-authored together Michael Roden links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 868 papers — load more, or switch the sort, to bring in the rest.

#Work
1
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
Hit paper breakdown →
20232204
2
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
Hit paper breakdown →
20232070
3
New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk
Hit paper breakdown →
20101857
4
Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes
Hit paper breakdown →
20121589
5
Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis
Hit paper breakdown →
20101480
6
Systematic identification of trans eQTLs as putative drivers of known disease associations
Hit paper breakdown →
20131350
7
Mechanism of free fatty acid-induced insulin resistance in humans.
Hit paper breakdown →
19961239
8
EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)
Hit paper breakdown →
20241179
9
Statin-associated muscle symptoms: impact on statin therapy—European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management
Hit paper breakdown →
20151143
10
Intramyocellular lipid concentrations are correlated with insulin sensitivity in humans: a 1 H NMR spectroscopy study
Hit paper breakdown →
19991049
11
Systematic review of reviews of intervention components associated with increased effectiveness in dietary and physical activity interventions
Hit paper breakdown →
2011940
12
The integrative biology of type 2 diabetes
Hit paper breakdown →
2019888
13
Genome-wide trans-ancestry meta-analysis provides insight into the genetic architecture of type 2 diabetes susceptibility
Hit paper breakdown →
2014881
14
Adaptation of Hepatic Mitochondrial Function in Humans with Non-Alcoholic Fatty Liver Is Lost in Steatohepatitis
Hit paper breakdown →
2015868
15
Identification of Serum Metabolites Associated With Risk of Type 2 Diabetes Using a Targeted Metabolomic Approach
Hit paper breakdown →
2012859
16
The genetic architecture of type 2 diabetes
Hit paper breakdown →
2016845
17
NAFLD and diabetes mellitus
Hit paper breakdown →
2016817
18
Epigenome-wide association study of body mass index, and the adverse outcomes of adiposity
Hit paper breakdown →
2016729
19
The complex link between NAFLD and type 2 diabetes mellitus — mechanisms and treatments
Hit paper breakdown →
2021659
20
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
Hit paper breakdown →
2023647

About Michael Roden

Michael Roden is a scholar working on Endocrinology, Diabetes and Metabolism, Epidemiology, Physiology, Genetics and Molecular Biology, having authored 868 papers that have together received 62k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (143 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (143 papers), Adipokines, Inflammation, and Metabolic Diseases (96 papers), Diabetes Management and Research (87 papers), Metabolism, Diabetes, and Cancer (74 papers), Diabetes Treatment and Management (71 papers), Pancreatic function and diabetes (56 papers) and Genetic Associations and Epidemiology (46 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (11.6k citations), Epidemiology (16k citations), Genetics (8.3k citations), Aging (425 citations) and Physiology (5.7k citations). Michael Roden has collaborated with scholars based in Germany, Austria and United States. Frequent co-authors include Gerald I. Shulman, Christian Herder, Julia Szendroedi, P. Nowotny, Werner K Waldhäusl, Martin Krššák, Douglas L. Rothman, Kitt Falk Petersen, Tomáš Jeleník and Gary W. Cline. Their work appears in journals such as Diabetes, Diabetologia, Diabetes Care, The Journal of Clinical Endocrinology & Metabolism and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact